Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (446)	6/26/2002 10:43:50 AM
From: Jibacoa	Read Replies (1) of 544

INGN is also swimming against the current today, apparently in response to its recent presentation at the 11th International p53 Workshop recently held in Barcelona, Spain.<g> INGN presented data on its ADVEXIN® p53 gene therapy (the old INGN 201 <g>)which appears to be safe and well-tolerated in a variety of cancers including head and neck, lung, ovarian, breast and brain and seems to have a good safety profile . INGN started with an up-gap today (albeit on low volume.<g>) siliconinvestor.com And it still needs to close above 2.50 to get off its down-trend.<g> siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next